Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infection.

Justyna D Kowalska, Amanda Mocroft, Anders Blaxhult, Robert Colebunders, Jan van Lunzen, Daria Podlekareva, Ann-Brit Eg Hansen, Ladislav Machala, Israel Yust, Thomas Benfield, NN NN

15 Citationer (Scopus)

Abstract

The role of hemoglobin levels as an independent prognostic marker of progression to AIDS and/or death in HIV-infected patients starting combination antiretroviral therapy (cART) was investigated. A total of 2,579 patients from the EuroSIDA cohort with hemoglobin, CD4 cell count, and HIV RNA viral load measured 6 months prior to starting cART was included in the analyses. Anemia was defined as mild (
Udgivelsesdato: 2007-Oct
OriginalsprogEngelsk
TidsskriftAIDS Research and Human Retroviruses
Vol/bind23
Udgave nummer10
Sider (fra-til)1183-8
Antal sider5
ISSN0889-2229
DOI
StatusUdgivet - 2007

Fingeraftryk

Dyk ned i forskningsemnerne om 'Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infection.'. Sammen danner de et unikt fingeraftryk.

Citationsformater